Transcutaneous heparin therapy. Experimental histological studies with the effective combination heparin--allantoin--D panthenol
Heine, H.
Die Medizinische Welt 34(20): 602-604
1983
ISSN/ISBN: 0025-8512 PMID: 6877066 Document Number: 201114
Document emailed within 1 workday
Related Documents
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125Tauschel, H.D.; Bonacina, F.; Galetti, F. 1984: The percutaneous action of a heparin-allantoin-dexpanthenol combination in a specific ointment base. Thrombolytic action on the rabbit ear Arzneimittel-Forschung 34(12): 1768-1772
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Willital, G.ün.H.; Simon, J. 2013: Efficacy of early initiation of a gel containing extractum cepae, heparin, and allantoin for scar treatment: an observational, noninterventional study of daily practice Journal of Drugs in Dermatology: Jdd 12(1): 38-42
Akmuradova, G.; Mishchenko, A.L.; Kazakova, L.A. 1985: Use of heparin in the combination therapy of parturients having undergone premature detachment of a normally positioned placenta Akusherstvo i Ginekologiia 6: 53-56
Dragani, L.; Colozzi, A.; Schiavone, C.; Obletter, G.; Celiberti, V.; Radico, S.; Vecchiet, L. 1989: A heparin-glucuronylglucosaminoglycan combination for topical use. An evaluation of the therapeutic effects in induced experimental muscle damage and in minor sports injuries Minerva Medica 80(4): 397-403
Torpie, R.J. 1974: Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats Journal of Medicine 5(1): 133-148
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Melissari, E.; Thye, C.; Scully, M.F.; Kakkar, V.V. 1989: Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells Thrombosis and Haemostasis 61(2): 262-265
Sampol, J.; Rossi, J.M.; Lejay, G. 1984: Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex Annales de Biologie Clinique 42(1): 21-23
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Kudriashov, B.A.; Liapina, L.A.; Molchanova, L.V.; Rustamova, B.A. 1970: Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin Voprosy Meditsinskoi Khimii 16(2): 161-168
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Izban, K.F.; Lietz, H.W.; Hoppensteadt, D.A.; Jeske, W.P.; Fareed, J.; Bakhos, M.; Walenga, J.M. 1999: Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia Seminars in Thrombosis and Hemostasis 25(Suppl 1): 51-56
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712